New York City is Taking on Shady Subscriptions
And TINA.org is all for it.
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Similasan Eye Relief products
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Settled
(Final approval granted)
https://www.homeopathiceyedropsettlement.com/home
And TINA.org is all for it.
Prediction market faces legal challenges on multiple fronts.
Julie O’Connor, NJ Spotlight News
Sara Talpos, Med Shadow
Ingredient claims come into the limelight.